I dont think the clinical results with Mustafa are as ideal as...

I dont think the clinical results with Mustafa are as ideal as well. Although this is offset by direct endorsements from aged care centers who have used the tool and have seen improvements in patients already, and also the abbey pain created Jennifer Abbey. This would only be more of a concern if we were still at prior to Aus and CE Mark European approval. We are past that now with these approvals.

On the painchek website about Us section, it says "Using AI and facial recognition technology, PainChek® provides carers across multiple clinical areas with three important new clinical benefits:"

That is the only sentence about AI on the about you page. in what situation would you then consider the use of 'Using AI and facial recognition' appropriate and satisfactory to your liking?

No clue about your query into the name... lol

"there is nothing ‘unique’ about painchek that can’t replicated (at this stage)- "
do you know any other AI companies who are specialised in pain detection methods for aged care? The FDA have classified this as De Novo, meaning no other company that is competing at this current time in this similiar area. Software is always at risk of being replicated in any type of market, yet there are many software companies that fly because of their value offering.